miltefosine has been researched along with Lung Diseases, Interstitial in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silva, JT | 1 |
| López-Medrano, F | 1 |
| Jimenez-Huerta, I | 1 |
| Lalueza, A | 1 |
| Fernández-Ruiz, M | 1 |
| Aguado, JM | 1 |
1 other study available for miltefosine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Miltefosine-induced acute interstitial pneumonitis in a patient with renal dysfunction.
Topics: Aged; Antiprotozoal Agents; Humans; Lung Diseases, Interstitial; Male; Phosphorylcholine; Renal Insu | 2013 |